Wenjun Shan

Dr. Wenjun Shan


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2018 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
WSWenjun Shan
Wenjun Shan
RCRonghe Chen
Ronghe Chen
QZQiang Zhang
Qiang Zhang
JZJie Zhao
Jie Zhao
BCBinbin Chen
Binbin Chen
Lei RenLei Ren
Lei Ren

1 April 2018 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
WSWenjun Shan
Wenjun Shan
DZDeliang Zhang
Deliang Zhang
YWYunlong Wu
Yunlong Wu
XLXiaolin Lv
Xiaolin Lv
BHBin Hu
Bin Hu
XZXianzhong Zhang
Xianzhong Zhang

6 February 2019 in Nano Letters
Verified
Journal Article
Closed access
WSWenjun Shan
Wenjun Shan
HZHaiping Zheng
Haiping Zheng
GFGuofeng Fu
Guofeng Fu
CLChenfeng Liu
Chenfeng Liu
ZLZizhen Li
Zizhen Li
GFGuo Fu
Guo Fu

1 January 2018 in Nanotheranostics
Verified
Journal Article
Open access
QZQiang Zhang
Qiang Zhang
WSWenjun Shan
Wenjun Shan
CAChaochao Ai
Chaochao Ai
ZCZhiwei Chen
Zhiwei Chen
TZTiantian Zhou
Tiantian Zhou
XWXiumin Wang
Xiumin Wang
To accomplish effective cancer imaging and integrated therapy, the multifunctional nanotheranostic Fe3O4-MTX@HBc core-shell nanoparticles (NPs) were designed. A straightforward method was demonstrated for efficient encapsulation of magnetic NPs into the engineered virus-like particles (VLPs) through the affinity of histidine tags for the methotrexate (MTX)-Ni2+ chelate. HBc144-His VLPs shell could protect Fe3O4-MTX NPs from the recognition by the reticuloendothelial system as well as could increase their cellular uptake efficiency. Through our well-designed tactic, the photothermal efficiency of Fe3O4 NPs were obviously improved in vitro and in vivo upon near-infrared (NIR) laser irradiation. Moreover, Magnetic resonance imaging (MRI) results showed that the Fe3O4-MTX@HBc core-shell NPs were reliable T2-type MRI contrast agents for tumor imaging. Hence the Fe3O4-MTX@HBc core-shell NPs may act as a promising theranostic platform for multimodal cancer treatment.

1 October 2021 in Biomaterials
Verified
Journal Article
Closed access
TLTao Liu
Tao Liu
QYQunfang Yang
Qunfang Yang
HZHaiping Zheng
Haiping Zheng
HJHonglin Jia
Honglin Jia
YHYufeng He
Yufeng He
WSWenjun Shan
Wenjun Shan

19 July 2016 in Discover Nano
Verified
Journal Article
Open access
PDF file
YWYarun Wang
Yarun Wang
YWYue Wang
Yue Wang
NKNing Kang
Ning Kang
YLYongliang Liu
Yongliang Liu
WSWenjun Shan
Wenjun Shan
GZGuohong Zhuang
Guohong Zhuang
Different types of vaccines have been developed to elicit active immunization to treat various diseases, while suffer from limitation of efficacy. Herein, a novel immunostimulatory nanocomposite (CpG-Au@HBc VLP) was rationally designed by self-assembling engineered virus-like particles encapsulating CpG-gold nanoparticle conjugates through electrostatic interactions. The monodispersed and uniformly sized CpG-Au@HBc VLP showed increased CD4+, CD8+ T cell numbers and stronger secretion of cytokine interferon-gamma than HBc VLPs adjuvanted with conventional Freund’s adjuvant. Furthermore, the use of Au nanoparticles also generated enhanced immunogenicity of CpG and VLPs on both humoral and cellular immune pathways, as followed from increased expressions of total HBc-specific antibody titer, CD4+ T cells, CD8+ T cells, cytokine interleukin-4, and interferon-gamma. These findings demonstrated that CpG-Au@HBc VLP nanocomposite could induce robust cellular and humoral immune response, which could be a potential vaccine for future prophylactic and therapeutic application.